logo

For the Inventor, By the Inventor

Frederiksberg, Denmark

Judith Margarete Gottwein

This inventor holds 19 USPTO granted patents and 1 published patent application and 7 EPO patents, primarily in Hepatitis C Research. Top assignees: Hvidovre Hospital, University of Copenhagen, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2013-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Judith Margarete Gottwein. Retrieved from https://idiyas.com/inventor/judith-margarete-gottwein

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 

% Patents Active = 52.6

 

Average Co-Inventor Count = 4.5

ph-index = 5

Forward Citations = 60(Granted Patents)


Location History:

  • Frederiksberg, DK (2013 - 2017)
  • Frederiksberg C, DK (2013 - 2019)

Company Filing History:

goldMedal19 out of 26 
 
Hvidovre Hospital
 patents
silverMedal4 out of 133 
 
University of Copenhagen
 patents
bronzeMedal3 out of 3,696 
 
The United States of America, as Represented by the Secretary, Department of Health and Human Services
 patents
where one patent can have more than one assignee

Years Active: 2013-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Hepatitis C Virus
Cell Culture System
Infectious Viruses
Vaccine Candidate
Genotype
Adaptive Mutations
Virus Particles
Direct-Acting Antivirals
High-Titer
Reporter Tagged Protein
Novel Mutations
Full-Length Infectious
19 patents (USPTO):Explore Patents
1. 12497598 - METHOD OF PURIFYING WHOLE VIRUS PARTICLES (2025-12-16),
2. 12104176 - Efficient cell culture system for hepatitis C virus genotype 6A (2024-10-01),
3. 10258687 - Development of methods for production of a whole virus vaccine candidate stock and novel adaptive mutations in hepatitis C virus (2019-04-16),
4. 10106783 - HCV culture systems and direct-acting antiviral sensitivity (2018-10-23),
5. 10106782 - High-titer HCV full-length genotype 2B infectious cell culture systems and applications thereof (2018-10-23),
6. 10100346 - Infectious hepatitis C viruses of genotype 3A and 4A and uses thereof (2018-10-16),
7. 9683269 - Infectious hepatitis C viruses of genotype 3A and 4A and uses thereof (2017-06-20),
8. 9388389 - JFH-1 based HCV cell culture systems for NS5A of genotypes 1-7 (2016-07-12),
9. 9382517 - HCV full-length infectious cell culture systems and applications thereof (2016-07-05),
10. 8946398 - Infectious hepatitis C viruses of genotype 3A and 4A and uses thereof (2015-02-03),
11. 8945584 - Cell culture system of a hepatitis C genotype 3a and 2a chimera (2015-02-03),
12. 8846891 - Infectious genotype 1a, 1b, 2a, 2b, 3a, 5a, 6a and 7a hepatitis C virus lacking the hypervariable region 1 (HVR1) (2014-09-30),
13. 8772022 - Hepatitis C virus expressing reporter tagged NS5A protein (2014-07-08),
14. 8663653 - Efficient cell culture system for hepatitis C virus genotype 2B (2014-03-04),
15. 8618275 - Efficient cell culture system for hepatitis C virus genotype 5A (2013-12-31),

Title: Judith Margarete Gottwein: Pioneering Innovator in Vaccine Development

Introduction:

Judith Margarete Gottwein, a visionary inventor based in Frederiksberg C, DK, is celebrated for her exceptional dedication to innovation and her remarkable contributions to the world of inventions. With a total of 17 patents to her name, Gottwein's work has significantly impacted the field of vaccine development, particularly in the areas of virus research and vaccine candidate stock production.

Latest Patents:

1. Development of methods for production of a whole virus vaccine candidate stock: In this patent, Gottwein introduces groundbreaking methods for obtaining a whole virus vaccine candidate stock. This invention also includes an inactivated whole virus vaccine candidate stock suitable for vaccination purposes and the development of novel high titer virus, crucial for this innovative technique.

2. High-titer HCV full-length genotype 2B infectious cell culture systems and applications thereof: Gottwein's patent focuses on nucleic acid sequences encoding hepatitis C viruses (HCV) of genotype 2b. These sequences play a vital role in fundamental HCV research and vaccine development. They are designed to express the virus when transfected into cells and demonstrate infectivity in vivo.

Career Highlights:

Gottwein has made significant contributions to renowned institutions such as Hvidovre Hospital and the University of Copenhagen (Kobenhavns Universitet). Her expertise and dedication have been instrumental in advancing research and development in the field of virology and vaccine technology.

Collaborations:

Throughout her illustrious career, Judith Margarete Gottwein has collaborated with esteemed colleagues such as Jens Bukh and Troels Kasper Hoyer Scheel. These fruitful partnerships have led to groundbreaking discoveries and innovative solutions in the realm of virus research and vaccine development.

Conclusion:

In conclusion, Judith Margarete Gottwein's pioneering spirit and unwavering commitment to innovation have established her as a true trailblazer in the field of vaccine development. Her impressive portfolio of patents and collaborative efforts exemplify her profound impact on the scientific community, solidifying her legacy as a leading innovator in the fight against infectious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…